Related Experiment Videos
Generation and characterization of a constitutively active Stat3 protein
Juan A Barboza1, Shuguang Wang, Timothy S Schaefer
1Department of Neurosurgery, UT M.D. Anderson Cancer Center Box 11, 1515 Holcombe Blvd., Houston, TX 77030, USA. jabarboza@mdanderson.org
Molecular Biology Reports
|March 26, 2004
Summary
Signal transducer and activator of transcription (STAT) proteins are crucial for cell signaling. Aberrant STAT activation, particularly STAT3, drives cancer; this study developed a novel STAT3beta-VAD protein to investigate its role in oncogenesis.
Area of Science:
- Molecular Biology
- Oncology
- Cellular Signaling
Background:
- Signal transducer and activator of transcription (STAT) proteins regulate normal cellular signaling.
- Constitutive activation of STATs, especially STAT3 and STAT5, is linked to cancer development.
- Elevated STAT activation is observed in various human tumors.
Purpose of the Study:
- To investigate the role of aberrant STAT activation in oncogenesis.
- To create and characterize a novel chimeric protein, STAT3beta-VAD, for studying STAT3 activity.
Main Methods:
- Constructed a chimeric molecule: STAT3beta fused with the VP16 activation domain (VAD).
- Assessed tyrosine phosphorylation, DNA binding, and transcriptional activity of STAT3beta-VAD.
- Examined the expression of endogenous c-myc and c-fos genes upon STAT3beta-VAD induction in COS-7 cells.
Main Results:
- STAT3beta-VAD demonstrates constitutive transcriptional activation without upstream stimulation.
- The chimeric protein is tyrosine phosphorylated and binds DNA independently.
- STAT3beta-VAD induces upregulation of c-myc and c-fos genes.
Conclusions:
- STAT3beta-VAD mimics the constitutive transcriptional activity of STAT3alpha found in human tumors.
- This novel protein serves as a valuable tool for screening STAT3-regulated genes.
- STAT3beta-VAD can aid in evaluating the contribution of other signaling pathways to cancer progression in the context of aberrant STAT3 activity.